<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">

Our History

25 Years and Beyond


Our History


  • Founded as Morwell Diagnostics GmbH in Zurich, Switzerland, provider of clinical diagnostic products.


  • Establishment of manufacturing facilities for clinical products. Representation and distribution in over 75 countries.


  • Establishment of MD Doctors Direct GmbH for the sale of point of care products into the clinic.

  • Formal distinction and formation of MD Biosciences for the manufacturing and sale of monoclonal research products and assays. Establishment of monoclonal production facility in Scotland for the production of ArthritoMab®


  • Establishment of contract research operations focused on joint inflammation


  • Expansion of contract research facilities with the establishment of in vivo facilities focused on all inflammatory diseases. Establishment of US based biomarker and assay development laboratories.


  • Establishment of new laboratory focused on neurodegenerative diseases and pain


  • Release of novel porcine translational models


  • Release of Senerga ® Phenotypic Screening Platform and formation of the first screening program with Jannsen Research


  • Expansion of US based in vivo operations to provide onco-immunology and metabolic disease focus


  • Establishment of CLIA accredited clinical analysis laboratory in the US

  • Separation of histology and immunohistochemistry laboratory operations as a business unit in conjunction with diagnostic operations

  • Expansion of investment and risk-sharing program for the development of compounds of interest


  • Research and development for MD 354 (chronic pain), MD 22 (inflammation/pain), and MD401B (canine osteocarcinoma vaccine), panel of biomarkers for gastrointestinal cancer diagnostics                      

  • Release of collaborative investment program to co-invest in promising early stage drug development.


Contact Us: 1-888-876-3246